172 related articles for article (PubMed ID: 14640911)
1. Cancer target discovery using SAGE.
Porter D; Polyak K
Expert Opin Ther Targets; 2003 Dec; 7(6):759-69. PubMed ID: 14640911
[TBL] [Abstract][Full Text] [Related]
2. Gene discovery using the serial analysis of gene expression technique: implications for cancer research.
Polyak K; Riggins GJ
J Clin Oncol; 2001 Jun; 19(11):2948-58. PubMed ID: 11387368
[TBL] [Abstract][Full Text] [Related]
3. SAGE and related approaches for cancer target identification.
Porter D; Yao J; Polyak K
Drug Discov Today; 2006 Feb; 11(3-4):110-8. PubMed ID: 16533708
[TBL] [Abstract][Full Text] [Related]
4. Genetic and epigenetic alterations as biomarkers for cancer detection, diagnosis and prognosis.
Herceg Z; Hainaut P
Mol Oncol; 2007 Jun; 1(1):26-41. PubMed ID: 19383285
[TBL] [Abstract][Full Text] [Related]
5. Technology evaluation: SAGE, Genzyme molecular oncology.
Bartlett J
Curr Opin Mol Ther; 2001 Feb; 3(1):85-96. PubMed ID: 11249736
[TBL] [Abstract][Full Text] [Related]
6. Serial analysis of gene expression (SAGE): application in cancer research.
Tuteja R; Tuteja N
Med Sci Monit; 2004 Jun; 10(6):RA132-40. PubMed ID: 15173683
[TBL] [Abstract][Full Text] [Related]
7. Not only P-glycoprotein: Amplification of the ABCB1-containing chromosome region 7q21 confers multidrug resistance upon cancer cells by coordinated overexpression of an assortment of resistance-related proteins.
Genovese I; Ilari A; Assaraf YG; Fazi F; Colotti G
Drug Resist Updat; 2017 May; 32():23-46. PubMed ID: 29145976
[TBL] [Abstract][Full Text] [Related]
8. Peculiarities of molecular events in human glial tumors revealed by serial analysis of gene expression (SAGE).
Kavsan V; Shostak K; Dmitrenko V; Chausovskiy T; Zozulya Y; Demotes-Mainard J
Exp Oncol; 2004 Sep; 26(3):196-204. PubMed ID: 15494687
[TBL] [Abstract][Full Text] [Related]
9. Rational design of cancer gene panels with OncoPaD.
Rubio-Perez C; Deu-Pons J; Tamborero D; Lopez-Bigas N; Gonzalez-Perez A
Genome Med; 2016 Oct; 8(1):98. PubMed ID: 27716338
[TBL] [Abstract][Full Text] [Related]
10. Implication of microRNAs in drug resistance for designing novel cancer therapy.
Sarkar FH; Li Y; Wang Z; Kong D; Ali S
Drug Resist Updat; 2010 Jun; 13(3):57-66. PubMed ID: 20236855
[TBL] [Abstract][Full Text] [Related]
11. A gene expression database for the molecular pharmacology of cancer.
Scherf U; Ross DT; Waltham M; Smith LH; Lee JK; Tanabe L; Kohn KW; Reinhold WC; Myers TG; Andrews DT; Scudiero DA; Eisen MB; Sausville EA; Pommier Y; Botstein D; Brown PO; Weinstein JN
Nat Genet; 2000 Mar; 24(3):236-44. PubMed ID: 10700175
[TBL] [Abstract][Full Text] [Related]
12. Application of Serial Analysis of Gene Expression in cancer research.
Yamashita T; Honda M; Kaneko S
Curr Pharm Biotechnol; 2008 Oct; 9(5):375-82. PubMed ID: 18855690
[TBL] [Abstract][Full Text] [Related]
13. Involvement of the multiple tumor suppressor genes and 12-lipoxygenase in human prostate cancer. Therapeutic implications.
Gao X; Porter AT; Honn KV
Adv Exp Med Biol; 1997; 407():41-53. PubMed ID: 9321930
[TBL] [Abstract][Full Text] [Related]
14. Identification of genes involved in squamous cell carcinoma of the lung using synchronized data from DNA copy number and transcript expression profiling analysis.
Lo KC; Stein LC; Panzarella JA; Cowell JK; Hawthorn L
Lung Cancer; 2008 Mar; 59(3):315-31. PubMed ID: 18029052
[TBL] [Abstract][Full Text] [Related]
15. DNA methylation: an epigenetic pathway to cancer and a promising target for anticancer therapy.
Worm J; Guldberg P
J Oral Pathol Med; 2002 Sep; 31(8):443-9. PubMed ID: 12220350
[TBL] [Abstract][Full Text] [Related]
16. From oncogene to network addiction: the new frontier of cancer genomics and therapeutics.
Tonon G
Future Oncol; 2008 Aug; 4(4):569-77. PubMed ID: 18684067
[TBL] [Abstract][Full Text] [Related]
17. Biomarkers of Bad Biology: Curse or a Blessing?
Banerjee S; Sicklick JK
Ann Surg Oncol; 2019 Feb; 26(2):318-320. PubMed ID: 30539488
[No Abstract] [Full Text] [Related]
18. Serial analysis of gene expression and cancer.
Hermeking H
Curr Opin Oncol; 2003 Jan; 15(1):44-9. PubMed ID: 12490760
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic mechanisms in tumorigenesis, tumor cell heterogeneity and drug resistance.
Wilting RH; Dannenberg JH
Drug Resist Updat; 2012; 15(1-2):21-38. PubMed ID: 22356866
[TBL] [Abstract][Full Text] [Related]
20. SAGE analysis highlights the importance of p53csv, ddx5, mapkapk2 and ranbp2 to multiple myeloma tumorigenesis.
Felix RS; Colleoni GW; Caballero OL; Yamamoto M; Almeida MS; Andrade VC; Chauffaille Mde L; Silva WA; Begnami MD; Soares FA; Simpson AJ; Zago MA; Vettore AL
Cancer Lett; 2009 Jun; 278(1):41-8. PubMed ID: 19171422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
